China's Newsoara pens $135M deal for remaining rights to vTv's inflammation drug
China's Newsoara pens $135M deal for remaining rights to vTv's inflammation drug
Body unavailable. Use the original source.
China's Newsoara pens $135M deal for remaining rights to vTv's inflammation drug
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.